nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGF2—cleft lip	0.775	1	CbGaD
Sucralfate—FGB—embryo—cleft lip	0.00403	0.187	CbGeAlD
Sucralfate—EGF—mouth—cleft lip	0.00353	0.164	CbGeAlD
Sucralfate—FGA—embryo—cleft lip	0.00345	0.16	CbGeAlD
Sucralfate—PGA5—head—cleft lip	0.003	0.139	CbGeAlD
Sucralfate—EGF—embryo—cleft lip	0.00252	0.117	CbGeAlD
Sucralfate—EGF—telencephalon—cleft lip	0.00205	0.0948	CbGeAlD
Sucralfate—FGA—head—cleft lip	0.00174	0.0808	CbGeAlD
Sucralfate—EGF—head—cleft lip	0.00127	0.059	CbGeAlD
Sucralfate—FGF2—DAP12 signaling—FGFR2—cleft lip	9.64e-05	0.000473	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—FGFR3—cleft lip	9.58e-05	0.000471	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—FGF2—cleft lip	9.58e-05	0.000471	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—FGFR1—cleft lip	9.54e-05	0.000469	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—FGF2—cleft lip	9.54e-05	0.000469	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—FGFR2—cleft lip	9.5e-05	0.000467	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	9.4e-05	0.000462	CbGpPWpGaD
Sucralfate—EGF—Disease—SLC19A1—cleft lip	9.37e-05	0.00046	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FGF3—cleft lip	9.36e-05	0.00046	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ARHGAP29—cleft lip	9.3e-05	0.000457	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	9.18e-05	0.000451	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—FGFR3—cleft lip	9.17e-05	0.00045	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—FGFR3—cleft lip	9.17e-05	0.00045	CbGpPWpGaD
Sucralfate—EGF—Disease—WNT3—cleft lip	9.13e-05	0.000449	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FGF9—cleft lip	9.12e-05	0.000448	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—FGFR1—cleft lip	9.12e-05	0.000448	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—FGFR1—cleft lip	9.1e-05	0.000447	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—FGFR1—cleft lip	9.07e-05	0.000446	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—FGFR2—cleft lip	9.07e-05	0.000445	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	9.07e-05	0.000445	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—FGFR2—cleft lip	9.07e-05	0.000445	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—FGFR1—cleft lip	9.03e-05	0.000443	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—FGF2—cleft lip	9.02e-05	0.000443	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—FGFR3—cleft lip	9.02e-05	0.000443	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—FGFR2—cleft lip	8.98e-05	0.000441	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—FGFR1—cleft lip	8.98e-05	0.000441	CbGpPWpGaD
Sucralfate—FGA—Disease—FGF8—cleft lip	8.93e-05	0.000439	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB3—cleft lip	8.91e-05	0.000438	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—FGFR2—cleft lip	8.91e-05	0.000437	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—FGFR2—cleft lip	8.87e-05	0.000436	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—FGFR1—cleft lip	8.85e-05	0.000435	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	8.64e-05	0.000424	CbGpPWpGaD
Sucralfate—FGA—Disease—MTR—cleft lip	8.62e-05	0.000424	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—FGFR3—cleft lip	8.61e-05	0.000423	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—MTHFR—cleft lip	8.61e-05	0.000423	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—FGFR3—cleft lip	8.6e-05	0.000422	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—FGFR3—cleft lip	8.57e-05	0.000421	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—FGFR3—cleft lip	8.53e-05	0.000419	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—FGFR3—cleft lip	8.49e-05	0.000417	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—FGFR1—cleft lip	8.45e-05	0.000415	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	8.45e-05	0.000415	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—FGFR1—cleft lip	8.45e-05	0.000415	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FGF3—cleft lip	8.43e-05	0.000414	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—FGFR2—cleft lip	8.39e-05	0.000412	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—FGFR1—cleft lip	8.37e-05	0.000411	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cleft lip	8.37e-05	0.000411	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—FGFR1—cleft lip	8.3e-05	0.000408	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—FGFR1—cleft lip	8.26e-05	0.000406	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FGF9—cleft lip	8.22e-05	0.000404	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FGF3—cleft lip	8.1e-05	0.000398	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—WNT9B—cleft lip	8.05e-05	0.000395	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	8.03e-05	0.000394	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—FGFR3—cleft lip	7.99e-05	0.000392	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	7.99e-05	0.000392	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—FGFR3—cleft lip	7.99e-05	0.000392	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	7.95e-05	0.000391	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—FGFR3—cleft lip	7.91e-05	0.000389	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FGF9—cleft lip	7.9e-05	0.000388	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—FGFR3—cleft lip	7.84e-05	0.000385	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—FGFR1—cleft lip	7.82e-05	0.000384	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—FGFR3—cleft lip	7.81e-05	0.000384	CbGpPWpGaD
Sucralfate—EGF—Disease—TCN2—cleft lip	7.76e-05	0.000381	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOG—cleft lip	7.72e-05	0.000379	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FGF10—cleft lip	7.7e-05	0.000378	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	7.48e-05	0.000368	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—FGFR3—cleft lip	7.39e-05	0.000363	CbGpPWpGaD
Sucralfate—FGF2—Disease—WNT9B—cleft lip	7.27e-05	0.000357	CbGpPWpGaD
Sucralfate—FGA—Disease—FGF3—cleft lip	7.27e-05	0.000357	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ABCA4—cleft lip	7.17e-05	0.000352	CbGpPWpGaD
Sucralfate—EGF—Immune System—SUMO1—cleft lip	7.15e-05	0.000351	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGF7—cleft lip	7.1e-05	0.000349	CbGpPWpGaD
Sucralfate—FGA—Disease—FGF9—cleft lip	7.09e-05	0.000348	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	7.07e-05	0.000347	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—MTHFR—cleft lip	7.01e-05	0.000344	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FGF10—cleft lip	6.94e-05	0.000341	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGF7—cleft lip	6.91e-05	0.00034	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SPRY2—cleft lip	6.91e-05	0.00034	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGF7—cleft lip	6.82e-05	0.000335	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—NOS3—cleft lip	6.79e-05	0.000334	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SPRY2—cleft lip	6.77e-05	0.000333	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SPRY2—cleft lip	6.77e-05	0.000333	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGF7—cleft lip	6.77e-05	0.000333	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGF7—cleft lip	6.77e-05	0.000333	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FGF10—cleft lip	6.66e-05	0.000327	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—NOS3—cleft lip	6.65e-05	0.000327	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—NOS3—cleft lip	6.65e-05	0.000327	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—MYC—cleft lip	6.65e-05	0.000327	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—FGF2—cleft lip	6.64e-05	0.000326	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IRF6—cleft lip	6.6e-05	0.000324	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGF8—cleft lip	6.56e-05	0.000322	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGF7—cleft lip	6.54e-05	0.000321	CbGpPWpGaD
Sucralfate—FGF2—Disease—ABCA4—cleft lip	6.48e-05	0.000318	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—WNT3—cleft lip	6.39e-05	0.000314	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGF8—cleft lip	6.38e-05	0.000313	CbGpPWpGaD
Sucralfate—FGF2—Neural Crest Differentiation—MYC—cleft lip	6.32e-05	0.00031	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGF8—cleft lip	6.3e-05	0.000309	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGF8—cleft lip	6.25e-05	0.000307	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGF8—cleft lip	6.25e-05	0.000307	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FGFR2—cleft lip	6.18e-05	0.000303	CbGpPWpGaD
Sucralfate—EGF—Disease—SPRY2—cleft lip	6.04e-05	0.000297	CbGpPWpGaD
Sucralfate—EGF—Disease—FGF7—cleft lip	6.04e-05	0.000297	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGF8—cleft lip	6.03e-05	0.000296	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	6e-05	0.000295	CbGpPWpGaD
Sucralfate—FGA—Disease—FGF10—cleft lip	5.98e-05	0.000294	CbGpPWpGaD
Sucralfate—FGF2—Disease—SLC19A1—cleft lip	5.93e-05	0.000291	CbGpPWpGaD
Sucralfate—FGF2—Disease—WNT3—cleft lip	5.78e-05	0.000284	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FGFR1—cleft lip	5.76e-05	0.000283	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PTCH1—cleft lip	5.73e-05	0.000281	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PTCH1—cleft lip	5.61e-05	0.000276	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PTCH1—cleft lip	5.61e-05	0.000276	CbGpPWpGaD
Sucralfate—EGF—Disease—FGF8—cleft lip	5.57e-05	0.000274	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FGFR2—cleft lip	5.57e-05	0.000273	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—MTHFR—cleft lip	5.57e-05	0.000273	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—FGFR3—cleft lip	5.44e-05	0.000267	CbGpPWpGaD
Sucralfate—EGF—Disease—MTR—cleft lip	5.38e-05	0.000264	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FGFR2—cleft lip	5.34e-05	0.000263	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGF3—cleft lip	5.34e-05	0.000262	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGF9—cleft lip	5.2e-05	0.000256	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGF3—cleft lip	5.19e-05	0.000255	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FGFR1—cleft lip	5.19e-05	0.000255	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGF3—cleft lip	5.13e-05	0.000252	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—WNT9B—cleft lip	5.09e-05	0.00025	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGF3—cleft lip	5.09e-05	0.00025	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGF3—cleft lip	5.09e-05	0.00025	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGF9—cleft lip	5.06e-05	0.000249	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGF9—cleft lip	5e-05	0.000246	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FGFR1—cleft lip	4.98e-05	0.000245	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—FGF10—cleft lip	4.97e-05	0.000244	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGF9—cleft lip	4.96e-05	0.000244	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGF9—cleft lip	4.96e-05	0.000244	CbGpPWpGaD
Sucralfate—FGF2—Disease—TCN2—cleft lip	4.91e-05	0.000241	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGF3—cleft lip	4.91e-05	0.000241	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FGFR3—cleft lip	4.9e-05	0.000241	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOG—cleft lip	4.88e-05	0.00024	CbGpPWpGaD
Sucralfate—FGA—Disease—FGFR2—cleft lip	4.8e-05	0.000236	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGF9—cleft lip	4.79e-05	0.000235	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FGFR3—cleft lip	4.71e-05	0.000231	CbGpPWpGaD
Sucralfate—FGA—Disease—MTHFR—cleft lip	4.62e-05	0.000227	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB3—cleft lip	4.59e-05	0.000226	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ABCA4—cleft lip	4.54e-05	0.000223	CbGpPWpGaD
Sucralfate—EGF—Disease—FGF3—cleft lip	4.54e-05	0.000223	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SUMO1—cleft lip	4.52e-05	0.000222	CbGpPWpGaD
Sucralfate—FGA—Disease—FGFR1—cleft lip	4.47e-05	0.00022	CbGpPWpGaD
Sucralfate—EGF—Disease—FGF9—cleft lip	4.42e-05	0.000217	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGF10—cleft lip	4.39e-05	0.000216	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGF10—cleft lip	4.27e-05	0.00021	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SPRY2—cleft lip	4.23e-05	0.000208	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF7—cleft lip	4.23e-05	0.000208	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCA4—cleft lip	4.23e-05	0.000208	CbGpPWpGaD
Sucralfate—FGA—Disease—FGFR3—cleft lip	4.22e-05	0.000208	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGF10—cleft lip	4.21e-05	0.000207	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGF10—cleft lip	4.18e-05	0.000206	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGF10—cleft lip	4.18e-05	0.000206	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—NOS3—cleft lip	4.15e-05	0.000204	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGF7—cleft lip	4.14e-05	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—WNT3—cleft lip	4.05e-05	0.000199	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGF10—cleft lip	4.04e-05	0.000198	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF8—cleft lip	3.9e-05	0.000192	CbGpPWpGaD
Sucralfate—FGF2—Disease—SPRY2—cleft lip	3.82e-05	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGF7—cleft lip	3.82e-05	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGF8—cleft lip	3.82e-05	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	3.8e-05	0.000186	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—FGF2—cleft lip	3.79e-05	0.000186	CbGpPWpGaD
Sucralfate—EGF—Disease—FGF10—cleft lip	3.73e-05	0.000183	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—FGFR1—cleft lip	3.72e-05	0.000183	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—FGF2—cleft lip	3.64e-05	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGF8—cleft lip	3.53e-05	0.000173	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGFR2—cleft lip	3.52e-05	0.000173	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTCH1—cleft lip	3.5e-05	0.000172	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGFR2—cleft lip	3.43e-05	0.000168	CbGpPWpGaD
Sucralfate—FGF2—Disease—MTR—cleft lip	3.41e-05	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGFR2—cleft lip	3.38e-05	0.000166	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGFR2—cleft lip	3.36e-05	0.000165	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGFR2—cleft lip	3.36e-05	0.000165	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGFR1—cleft lip	3.28e-05	0.000161	CbGpPWpGaD
Sucralfate—FGA—Disease—FGF2—cleft lip	3.26e-05	0.00016	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGFR2—cleft lip	3.24e-05	0.000159	CbGpPWpGaD
Sucralfate—FGA—Disease—NOS3—cleft lip	3.22e-05	0.000158	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGFR1—cleft lip	3.2e-05	0.000157	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF3—cleft lip	3.18e-05	0.000156	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGFR1—cleft lip	3.15e-05	0.000155	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGFR1—cleft lip	3.13e-05	0.000154	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGFR1—cleft lip	3.13e-05	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGF3—cleft lip	3.11e-05	0.000153	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FGFR3—cleft lip	3.1e-05	0.000152	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF9—cleft lip	3.1e-05	0.000152	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGF9—cleft lip	3.03e-05	0.000149	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGFR1—cleft lip	3.02e-05	0.000148	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGFR3—cleft lip	3.02e-05	0.000148	CbGpPWpGaD
Sucralfate—EGF—Disease—FGFR2—cleft lip	2.99e-05	0.000147	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FGFR3—cleft lip	2.98e-05	0.000146	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGFR3—cleft lip	2.96e-05	0.000145	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGFR3—cleft lip	2.96e-05	0.000145	CbGpPWpGaD
Sucralfate—EGF—Disease—MTHFR—cleft lip	2.88e-05	0.000142	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGF3—cleft lip	2.87e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGFR3—cleft lip	2.86e-05	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGF9—cleft lip	2.8e-05	0.000137	CbGpPWpGaD
Sucralfate—EGF—Disease—FGFR1—cleft lip	2.79e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SPRY2—cleft lip	2.68e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF7—cleft lip	2.68e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Disease—FGFR3—cleft lip	2.64e-05	0.00013	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF10—cleft lip	2.61e-05	0.000128	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGF10—cleft lip	2.56e-05	0.000126	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF8—cleft lip	2.47e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGF10—cleft lip	2.36e-05	0.000116	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FGF2—cleft lip	2.33e-05	0.000115	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOS3—cleft lip	2.3e-05	0.000113	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FGF2—cleft lip	2.29e-05	0.000112	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FGF2—cleft lip	2.29e-05	0.000112	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOS3—cleft lip	2.25e-05	0.000111	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOS3—cleft lip	2.25e-05	0.000111	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTCH1—cleft lip	2.22e-05	0.000109	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGF2—cleft lip	2.21e-05	0.000108	CbGpPWpGaD
Sucralfate—FGA—Disease—MYC—cleft lip	2.13e-05	0.000105	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGFR2—cleft lip	2.1e-05	0.000103	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGFR2—cleft lip	2.05e-05	0.000101	CbGpPWpGaD
Sucralfate—EGF—Disease—FGF2—cleft lip	2.04e-05	0.0001	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF3—cleft lip	2.01e-05	9.87e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS3—cleft lip	2.01e-05	9.87e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF9—cleft lip	1.96e-05	9.63e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGFR1—cleft lip	1.95e-05	9.6e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGFR1—cleft lip	1.91e-05	9.39e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGFR2—cleft lip	1.89e-05	9.31e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGFR3—cleft lip	1.85e-05	9.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MTHFR—cleft lip	1.82e-05	8.96e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SLC19A1—cleft lip	1.81e-05	8.89e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGFR3—cleft lip	1.81e-05	8.88e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGFR1—cleft lip	1.77e-05	8.67e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGFR3—cleft lip	1.67e-05	8.2e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF10—cleft lip	1.65e-05	8.12e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MYC—cleft lip	1.53e-05	7.49e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TCN2—cleft lip	1.5e-05	7.37e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MYC—cleft lip	1.49e-05	7.34e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MYC—cleft lip	1.49e-05	7.34e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF2—cleft lip	1.43e-05	7.01e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOS3—cleft lip	1.41e-05	6.91e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—MYC—cleft lip	1.33e-05	6.54e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGFR2—cleft lip	1.33e-05	6.52e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS3—cleft lip	1.27e-05	6.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGFR1—cleft lip	1.24e-05	6.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGFR3—cleft lip	1.17e-05	5.74e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTR—cleft lip	1.04e-05	5.11e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS3—cleft lip	9.58e-06	4.71e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MYC—cleft lip	9.33e-06	4.58e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOS3—cleft lip	8.91e-06	4.37e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—MYC—cleft lip	8.43e-06	4.14e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TYMS—cleft lip	6.37e-06	3.13e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MYC—cleft lip	5.9e-06	2.9e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTHFR—cleft lip	5.57e-06	2.74e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NOS3—cleft lip	3.88e-06	1.91e-05	CbGpPWpGaD
